You are being redirected to the story the piece of content is found in so you can read it in context. Please click the following link if you are not automatically redirected within a couple seconds:

Drug Access: GSK Gives Consent to Canadian Drug Company To Manufacture Generic Antiretroviral for Rwanda

Author: Kaiser Network Daily HIV/AIDS Report [USA], Published on: 10 August 2007

GlaxoSmithKline on Wednesday announced that it has given consent to Toronto-based drug company Apotex to use two of its patented antiretroviral manufacture Apo-triAvir -- a fixed-dose combination of the two drugs and the antiretroviral nevirapine -- for Rwanda... Boehringer Ingelheim agreed last month to allow Apotex to use its antiretroviral nevirapine in the combination therapy...

Read the full post here

Related companies: Apotex Boehringer Ingelheim GlaxoSmithKline